Epistemis

Isolated peripheral cyanosis

Specialty: Cardiovascular.

  • transient acrocyanosis
  • blue extremities due to cardiovascular causes
  • distal cyanosis without central hypoxemia

Why it occurs

  • Congestive heart failure with low output and flow redistribution
  • Cardiogenic or hypovolemic shock with extreme peripheral vasoconstriction
  • Severe cold exposure with reflex vascular spasm
  • Peripheral occlusive arterial disease of the affected extremities
  • Blood hyperviscosity syndromes (polycythemia vera, leukemia)

Initial workup

Arterial gasometry simultaneous with measurement with peripheral pulse oximeter to document the dissociation between central arterial oxygen saturation (normal) and local hypoperfusion; Emergency transthoracic echocardiogram to evaluate biventricular systolic function and rule out shock from obstructive (tamponade, pulmonary embolism) or myocardial causes; Complete analysis that includes a complete blood count (ruling out polyglobulia), lipid profile, serum lactate (marker of tissue hypoperfusion) and kidney function.

red flags

Bluish or violet discoloration located exclusively on the fingers, toes, earlobes or tip of the nose, which occurs in a patient with normal arterial oxygen saturation by central pulse oximetry (e.g. >95% in warm earlobe or normal arterial blood gas), but is associated with profound hypotension (SBP <90 mmHg), skin coldness generalized symmetrical, stupor, oliguria (<0.5 mL/kg/h) or threadlike pulse. These signs suggest shock of cardiogenic or distributive origin with poor systemic tissue perfusion, requiring invasive monitoring and hemodynamic support.

Standard management

  • Norepinephrine — vasopressor indicated in deep shock if there is associated hypotension to optimize perfusion to target organs; infusion of 0.05 to 0.5 mcg/kg/min
  • Dobutamine — beta-adrenergic inotrope indicated if the origin of peripheral cyanosis is very low cardiac output due to refractory systolic heart failure; continuous infusion of 2.5 to 10 mcg/kg/min
  • Acetylsalicylic acid — antiplatelet indicated if associated peripheral arterial occlusive disease is confirmed; 100 mg per day orally
  • Pentoxifylline (hemorheological agent useful in chronic peripheral circulatory disorders; 400 mg three times a day orally).

Educational guidance for study. It is NOT a prescription recommendation. The actual choice depends on the cause, the patient, and current guidelines.

PreviousCyanosis
Area
Cardiovascular
Listed causes
5
Treatment options
4
Download Epistemis